Home Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

FPG #8: Alternative Treatments in Psychiatry
FPG #7: Critical Care in Neurology

Free Medical Books

  Dermatology

  Free Subscription


Articles published in Cancer

Retrieve available abstracts of 114 articles:
HTML format
Text format



Single Articles


    January 2012
  1. HWA C , Price LS, Belitskaya-Levy I, Ma MW, et al
    Single versus multiple primary melanomas: Old questions and new answers.
    Cancer. 2012 Jan 13. doi: 10.1002/cncr.27407.
    PubMed     Text format     Related articles    Abstract available



  2. PRINTZ C
    Study finds heart transplant patients may be at risk for serious skin cancers.
    Cancer. 2012;118:3.
    PubMed     Text format     Related articles   



    December 2011
  3. JAKOB JA , Bassett RL Jr, Ng CS, Curry JL, et al
    NRAS mutation status is an independent prognostic factor in metastatic melanoma.
    Cancer. 2011 Dec 16. doi: 10.1002/cncr.26724.
    PubMed     Text format     Related articles    Abstract available



  4. SWETTER SM , Pollitt RA, Johnson TM, Brooks DR, et al
    Behavioral determinants of successful early melanoma detection: Role of self and physician skin examination.
    Cancer. 2011 Dec 16. doi: 10.1002/cncr.26707.
    PubMed     Text format     Related articles    Abstract available



  5. POLLITT RA , Swetter SM, Johnson TM, Patil P, et al
    Examining the pathways linking lower socioeconomic status and advanced melanoma.
    Cancer. 2011 Dec 16. doi: 10.1002/cncr.26706.
    PubMed     Text format     Related articles    Abstract available



  6. PRINTZ C
    Researchers report discoveries in cancer progression and rare skin and pancreatic cancers.
    Cancer. 2011;117:5435.
    PubMed     Text format     Related articles   



  7. TRIVERS KF , Baldwin LM, Miller JW, Matthews B, et al
    Reported referral for genetic counseling or BRCA 1/2 testing among United States physicians: a vignette-based study.
    Cancer. 2011;117:5334-43.
    PubMed     Text format     Related articles    Abstract available



    November 2011
  8. PRINTZ C
    Bevacizumab recommendation highlights difficulties.
    Cancer. 2011;117:5025.
    PubMed     Text format     Related articles   



    October 2011
  9. WANG WL , Bones-Valentin RA, Prieto VG, Pollock RE, et al
    Sarcoma metastases to the skin: A clinicopathologic study of 65 patients.
    Cancer. 2011 Oct 11. doi: 10.1002/cncr.26590.
    PubMed     Text format     Related articles    Abstract available



  10. PRINTZ C
    Duke University researchers develop laser-based tool for melanoma.
    Cancer. 2011;117:4338-9.
    PubMed     Text format     Related articles   



  11. PRINTZ C
    Test may help predict chemotherapy response and survival in breast cancer.
    Cancer. 2011;117:4339.
    PubMed     Text format     Related articles   



    September 2011
  12. JENSEN TO , Schmidt H, Moller HJ, Donskov F, et al
    Intratumoral neutrophils and plasmacytoid dendritic cells indicate poor prognosis and are associated with pSTAT3 expression in AJCC stage I/II melanoma.
    Cancer. 2011 Sep 22. doi: 10.1002/cncr.26511.
    PubMed     Text format     Related articles    Abstract available



  13. PRINTZ C
    Hair loss at 20 associated with prostate cancer risk later in life.
    Cancer. 2011;117:4105.
    PubMed     Text format     Related articles   



  14. FORSYTH RA
    Effectiveness of population-based service screening with mammography for women ages 40 to 49 years.
    Cancer. 2011;117:4100.
    PubMed     Text format     Related articles   



  15. WEIHUA Z , Lin Q, Ramoth AJ, Fan D, et al
    Formation of solid tumors by a single multinucleated cancer cell.
    Cancer. 2011;117:4092-9.
    PubMed     Text format     Related articles    Abstract available



    August 2011
  16. KADAKIA KC , Barton DL, Loprinzi CL, Sloan JA, et al
    Randomized controlled trial of acitretin versus placebo in patients at high-risk for basal cell or squamous cell carcinoma of the skin (North Central Cancer Treatment Group Study 969251).
    Cancer. 2011 Aug 31. doi: 10.1002/cncr.26374.
    PubMed     Text format     Related articles    Abstract available



  17. HOFFMAN HJ , Laverda NL, Levine PH, Young HA, et al
    Having health insurance does not eliminate race/ethnicity-associated delays in breast cancer diagnosis in the District of Columbia.
    Cancer. 2011;117:3824-32.
    PubMed     Text format     Related articles    Abstract available



  18. PAXTON RJ , Jones LA, Chang S, Hernandez M, et al
    Was race a factor in the outcomes of the Women's Health Eating and Living Study?
    Cancer. 2011;117:3805-13.
    PubMed     Text format     Related articles    Abstract available



  19. HOLMES P , Lloyd J, Chervoneva I, Pequinot E, et al
    Prognostic markers and long-term outcomes in ductal carcinoma in situ of the breast treated with excision alone.
    Cancer. 2011;117:3650-7.
    PubMed     Text format     Related articles    Abstract available



  20. NAOI Y , Kishi K, Tanei T, Tsunashima R, et al
    Prediction of pathologic complete response to sequential paclitaxel and 5-fluorouracil/epirubicin/cyclophosphamide therapy using a 70-gene classifier for breast cancers.
    Cancer. 2011;117:3682-90.
    PubMed     Text format     Related articles    Abstract available



    July 2011
  21. ERMAN AB , Collar RM, Griffith KA, Lowe L, et al
    Sentinel lymph node biopsy is accurate and prognostic in head and neck melanoma.
    Cancer. 2011 Jul 19. doi: 10.1002/cncr.26288.
    PubMed     Text format     Related articles    Abstract available



  22. GANAI S , Winchester DJ
    Screening mammography: bringing back into focus the value of a lifesaving intervention.
    Cancer. 2011;117:3062-3.
    PubMed     Text format     Related articles   



  23. PRINTZ C
    Lymph node study leads to changes in breast cancer treatment: A subset of patients do not have poorer survival when fewer lymph nodes are removed.
    Cancer. 2011;117:3061-2.
    PubMed     Text format     Related articles   



  24. WU ZS , Wu Q, Wang CQ, Wang XN, et al
    miR-340 inhibition of breast cancer cell migration and invasion through targeting of oncoprotein c-Met.
    Cancer. 2011;117:2842-52.
    PubMed     Text format     Related articles    Abstract available



  25. PRINTZ C
    Smoking studies produce new findings regarding breast and lung cancer link.
    Cancer. 2011;117:2828-9.
    PubMed     Text format     Related articles   



  26. HU YY , Weeks CM, In H, Dodgion CM, et al
    Impact of neoadjuvant chemotherapy on breast reconstruction.
    Cancer. 2011;117:2833-41.
    PubMed     Text format     Related articles    Abstract available



  27. KEATING NL , O'Malley AJ, Murabito JM, Smith KP, et al
    Minimal social network effects evident in cancer screening behavior.
    Cancer. 2011;117:3045-52.
    PubMed     Text format     Related articles    Abstract available



    June 2011
  28. ZHANG Z , Chen G, Cheng Y, Martinka M, et al
    Prognostic significance of RUNX3 expression in human melanoma.
    Cancer. 2011;117:2719-27.
    PubMed     Text format     Related articles    Abstract available



  29. AMIRIKIA KC , Mills P, Bush J, Newman LA, et al
    Higher population-based incidence rates of triple-negative breast cancer among young African-American women : Implications for breast cancer screening recommendations.
    Cancer. 2011;117:2747-53.
    PubMed     Text format     Related articles    Abstract available



  30. WESTIN SN , Sun CC, Lu KH, Schmeler KM, et al
    Satisfaction with ovarian carcinoma risk-reduction strategies among women at high risk for breast and ovarian carcinoma.
    Cancer. 2011;117:2659-67.
    PubMed     Text format     Related articles    Abstract available



  31. HILL EK , Sandbo S, Abramsohn E, Makelarski J, et al
    Assessing gynecologic and breast cancer survivors' sexual health care needs.
    Cancer. 2011;117:2643-51.
    PubMed     Text format     Related articles    Abstract available



  32. DRAGUN AE , Huang B, Tucker TC, Spanos WJ, et al
    Disparities in the application of adjuvant radiotherapy after breast-conserving surgery for early stage breast cancer: Impact on overall survival.
    Cancer. 2011;117:2590-8.
    PubMed     Text format     Related articles    Abstract available



  33. FELDMAN S , Krishnamurthy S, Gillanders W, Gittleman M, et al
    A novel automated assay for the rapid identification of metastatic breast carcinoma in sentinel lymph nodes.
    Cancer. 2011;117:2599-607.
    PubMed     Text format     Related articles    Abstract available



    May 2011
  34. SEXTON KR , Franzini L, Day RS, Brewster A, et al
    A review of body size and breast cancer risk in Hispanic and African American women.
    Cancer. 2011 May 19. doi: 10.1002/cncr.26217.
    PubMed     Text format     Related articles    Abstract available



  35. KLUGER HM , Dudek AZ, McCann C, Ritacco J, et al
    A phase 2 trial of dasatinib in advanced melanoma.
    Cancer. 2011;117:2202-8.
    PubMed     Text format     Related articles   



  36. GADIOT J , Hooijkaas AI, Kaiser AD, van Tinteren H, et al
    Overall survival and PD-L1 expression in metastasized malignant melanoma.
    Cancer. 2011;117:2192-201.
    PubMed     Text format     Related articles   



  37. BREEN N , Gentleman JF, Schiller JS
    Update on mammography trends: comparisons of rates in 2000, 2005, and 2008.
    Cancer. 2011;117:2209-18.
    PubMed     Text format     Related articles    Abstract available



  38. PANET-RAYMOND V , Truong PT, Alexander C, Lesperance M, et al
    Clinicopathologic factors of the recurrent tumor predict outcome in patients with ipsilateral breast tumor recurrence.
    Cancer. 2011;117:2035-43.
    PubMed     Text format     Related articles    Abstract available



  39. FANG M , Toher J, Morgan M, Davison J, et al
    Genomic differences between estrogen receptor (ER)-positive and ER-negative human breast carcinoma identified by single nucleotide polymorphism array comparative genome hybridization analysis.
    Cancer. 2011;117:2024-34.
    PubMed     Text format     Related articles    Abstract available



  40. MCLAUGHLIN JM , Fisher JL, Paskett ED
    Marital status and stage at diagnosis of cutaneous melanoma: Results from the Surveillance Epidemiology and End Results (SEER) program, 1973-2006.
    Cancer. 2011;117:1984-93.
    PubMed     Text format     Related articles    Abstract available



  41. NEWCOMB PA , Trentham-Dietz A, Hampton JM, Egan KM, et al
    Late age at first full term birth is strongly associated with lobular breast cancer.
    Cancer. 2011;117:1946-1956.
    PubMed     Text format     Related articles    Abstract available



  42. MUSOLINO A , Ciccolallo L, Panebianco M, Fontana E, et al
    Multifactorial central nervous system recurrence susceptibility in patients with HER2-positive breast cancer: Epidemiological and clinical data from a population-based cancer registry study.
    Cancer. 2011;117:1837-46.
    PubMed     Text format     Related articles    Abstract available



  43. DAWOOD S , Ueno NT, Valero V, Woodward WA, et al
    Differences in survival among women with stage III inflammatory and noninflammatory locally advanced breast cancer appear early: A large population-based study.
    Cancer. 2011;117:1819-26.
    PubMed     Text format     Related articles    Abstract available



  44. BORDELEAU L , Lipscombe L, Lubinski J, Ghadirian P, et al
    Diabetes and breast cancer among women with BRCA1 and BRCA2 mutations.
    Cancer. 2011;117:1812-1818.
    PubMed     Text format     Related articles    Abstract available



    April 2011
  45. ZAKRZEWSKI J , Geraghty LN, Rose AE, Christos PJ, et al
    Clinical variables and primary tumor characteristics predictive of the development of melanoma brain metastases and post-brain metastases survival.
    Cancer. 2011;117:1711-20.
    PubMed     Text format     Related articles    Abstract available



  46. KOTTSCHADE LA , Suman VJ, Amatruda T 3rd, McWilliams RR, et al
    A phase II trial of nab-paclitaxel (ABI-007) and carboplatin in patients with unresectable stage IV melanoma : A North Central Cancer Treatment Group Study, N057E(1).
    Cancer. 2011;117:1704-10.
    PubMed     Text format     Related articles    Abstract available



  47. EIGENTLER TK , Figl A, Krex D, Mohr P, et al
    Number of metastases, serum lactate dehydrogenase level, and type of treatment are prognostic factors in patients with brain metastases of malignant melanoma.
    Cancer. 2011;117:1697-1703.
    PubMed     Text format     Related articles    Abstract available



  48. OTHUS M , Moon J, Margolin K
    Melanoma's deadly march to the brain: By what route, and can it be stopped?
    Cancer. 2011;117:1560-3.
    PubMed     Text format     Related articles   



  49. BAENA-CANADA JM , Estalella S, Rosado P
    Cytologically proven axillary lymph node metastases are eradicated in patients receiving preoperative chemotherapy with concurrent trastuzumab for HER2-positive breast cancer.
    Cancer. 2011;117:1783.
    PubMed     Text format     Related articles   



  50. CHAMPION L , Brain E, Giraudet AL, Le Stanc E, et al
    Breast cancer recurrence diagnosis suspected on tumor marker rising: Value of whole-body 18FDG-PET/CT imaging and impact on patient management.
    Cancer. 2011;117:1621-9.
    PubMed     Text format     Related articles    Abstract available



  51. ANDERS CK , Deal AM, Miller CR, Khorram C, et al
    The prognostic contribution of clinical breast cancer subtype, age, and race among patients with breast cancer brain metastases.
    Cancer. 2011;117:1602-11.
    PubMed     Text format     Related articles    Abstract available



  52. ALBERT JM , Gonzalez-Angulo AM, Guray M, Sahin A, et al
    Patients with only 1 positive hormone receptor have increased locoregional recurrence compared with patients with estrogen receptor-positive progesterone receptor-positive disease in very early stage breast cancer.
    Cancer. 2011;117:1595-601.
    PubMed     Text format     Related articles    Abstract available



  53. KAUFMANN M , Pusztai L
    Use of standard markers and incorporation of molecular markers into breast cancer therapy: Consensus recommendations from an International Expert Panel.
    Cancer. 2011;117:1575-1582.
    PubMed     Text format     Related articles    Abstract available



  54. PRINTZ C
    "Stand up to cancer" focuses on accelerating promising research: campaign has raised approximately $180 million.
    Cancer. 2011;117:1557-9.
    PubMed     Text format     Related articles   



  55. BERKEY CS , Willett WC, Frazier AL, Rosner B, et al
    Prospective study of growth and development in older girls and risk of benign breast disease in young women.
    Cancer. 2011;117:1612-20.
    PubMed     Text format     Related articles    Abstract available



  56. SPRAGUE BL , Trentham-Dietz A, Gangnon RE, Ramchandani R, et al
    Socioeconomic status and survival after an invasive breast cancer diagnosis.
    Cancer. 2011;117:1542-51.
    PubMed     Text format     Related articles    Abstract available



  57. LECHNER MG , Lade S, Liebertz DJ, Prince HM, et al
    Breast implant-associated, ALK-negative, T-cell, anaplastic, large-cell lymphoma: Establishment and characterization of a model cell line (TLBR-1) for this newly emerging clinical entity.
    Cancer. 2011;117:1478-89.
    PubMed     Text format     Related articles    Abstract available



  58. SMALL BJ , Rawson KS, Walsh E, Jim HS, et al
    Catechol-O-methyltransferase genotype modulates cancer treatment-related cognitive deficits in breast cancer survivors.
    Cancer. 2011;117:1369-76.
    PubMed     Text format     Related articles    Abstract available



  59. NAGTEGAAL ID , Allgood PC, Duffy SW, Kearins O, et al
    Prognosis and pathology of screen-detected carcinomas: how different are they?
    Cancer. 2011;117:1360-8.
    PubMed     Text format     Related articles   



  60. MULLIGAN AM , Pinnaduwage D, Bane AL, Bull SB, et al
    CK8/18 expression, the basal phenotype, and family history in identifying BRCA1-associated breast cancer in the Ontario site of the Breast Cancer Family Registry.
    Cancer. 2011;117:1350-9.
    PubMed     Text format     Related articles    Abstract available



    March 2011
  61. KIRKWOOD JM , Gonzalez R, Reintgen D, Clingan PR, et al
    A phase 2 study of tasisulam sodium (LY573636 sodium) as second-line treatment for patients with unresectable or metastatic melanoma.
    Cancer. 2011 Mar 31. doi: 10.1002/cncr.26068.
    PubMed     Text format     Related articles    Abstract available



  62. SOSMAN JA , Moon J, Tuthill RJ, Warneke JA, et al
    A phase 2 trial of complete resection for stage IV melanoma: Results of Southwest Oncology Group Clinical Trial S9430.
    Cancer. 2011 Mar 31. doi: 10.1002/cncr.26111.
    PubMed     Text format     Related articles    Abstract available



  63. OLLILA DW
    A phase 2 trial of complete resection for stage IV melanoma : Results of Southwest Oncology Group Clinical Trial S9430.
    Cancer. 2011 Mar 31. doi: 10.1002/cncr.26118.
    PubMed     Text format     Related articles   



  64. KELLY P , Zagars GK, Cormier JN, Ross MI, et al
    Sphincter-sparing local excision and hypofractionated radiation therapy for anorectal melanoma: A 20-Year Experience.
    Cancer. 2011 Mar 28. doi: 10.1002/cncr.26088.
    PubMed     Text format     Related articles    Abstract available



  65. JANZ NK , Hawley ST, Mujahid MS, Griggs JJ, et al
    Correlates of worry about recurrence in a multiethnic population-based sample of women with breast cancer.
    Cancer. 2011 Mar 28. doi: 10.1002/cncr.25740.
    PubMed     Text format     Related articles    Abstract available



  66. MAZUREK N , Byrd JC, Sun Y, Ueno S, et al
    A galectin-3 sequence polymorphism confers TRAIL sensitivity to human breast cancer cells.
    Cancer. 2011 Mar 28. doi: 10.1002/cncr.26078.
    PubMed     Text format     Related articles    Abstract available



  67. OSAKO T , Iwase T, Kimura K, Yamashita K, et al
    Intraoperative molecular assay for sentinel lymph node metastases in early stage breast cancer: A comparative analysis between one-step nucleic acid amplification whole node assay and routine frozen section histology.
    Cancer. 2011 Mar 22. doi: 10.1002/cncr.26060.
    PubMed     Text format     Related articles    Abstract available



  68. UCHINO K , Tateishi R, Shiina S, Kanda M, et al
    Hepatocellular carcinoma with extrahepatic metastasis: Clinical features and prognostic factors.
    Cancer. 2011 Mar 22. doi: 10.1002/cncr.25960.
    PubMed     Text format     Related articles    Abstract available



  69. ERINJERI JP , Fong AJ, Kemeny NE, Brown KT, et al
    Timing of administration of bevacizumab chemotherapy affects wound healing after chest wall port placement.
    Cancer. 2011;117:1296-301.
    PubMed     Text format     Related articles    Abstract available



  70. MOTWANI SB , Goyal S, Moran MS, Chhabra A, et al
    Ductal carcinoma in situ treated with breast-conserving surgery and radiotherapy: a comparison with ECOG study 5194.
    Cancer. 2011;117:1156-62.
    PubMed     Text format     Related articles    Abstract available



  71. GOYAL S , Vicini F, Beitsch PD, Kuerer H, et al
    Ductal carcinoma in situ treated with breast-conserving surgery and accelerated partial breast irradiation: comparison of the Mammosite registry trial with intergroup study E5194.
    Cancer. 2011;117:1149-55.
    PubMed     Text format     Related articles    Abstract available



  72. PRINTZ C
    Symposium zeroes in on new discoveries in breast cancer.
    Cancer. 2011;117:1107-8.
    PubMed     Text format     Related articles   



  73. NOAH-VANHOUCKE J , Green LE, Dinh TA, Alperin P, et al
    Cost-effectiveness of chemoprevention of breast cancer using tamoxifen in a postmenopausal US population.
    Cancer. 2011 Mar 14. doi: 10.1002/cncr.25926.
    PubMed     Text format     Related articles    Abstract available



  74. LARA-MEDINA F , Perez-Sanchez V, Saavedra-Perez D, Blake-Cerda M, et al
    Triple-negative breast cancer in hispanic patients: High prevalence, poor prognosis, and association with menopausal status, body mass index, and parity.
    Cancer. 2011 Mar 8. doi: 10.1002/cncr.25961.
    PubMed     Text format     Related articles    Abstract available



  75. ADEMUYIWA FO , Groman A, O'Connor T, Ambrosone C, et al
    Impact of body mass index on clinical outcomes in triple-negative breast cancer.
    Cancer. 2011 Mar 8. doi: 10.1002/cncr.26019.
    PubMed     Text format     Related articles    Abstract available



  76. GAJRIA D , Feigin K, Tan LK, Patil S, et al
    Phase 2 trial of a novel capecitabine dosing schedule in combination with bevacizumab for patients with metastatic breast cancer.
    Cancer. 2011 Mar 8. doi: 10.1002/cncr.25992.
    PubMed     Text format     Related articles    Abstract available



  77. LE-PETROSS HT , Whitman GJ, Atchley DP, Yuan Y, et al
    Effectiveness of alternating mammography and magnetic resonance imaging for screening women with deleterious BRCA mutations at high risk of breast cancer.
    Cancer. 2011 Mar 1. doi: 10.1002/cncr.25971.
    PubMed     Text format     Related articles    Abstract available



  78. TAUNK NK , Haffty BG, Chen S, Khan AJ, et al
    Comparison of radiation-induced fatigue across 3 different radiotherapeutic methods for early stage breast cancer.
    Cancer. 2011 Mar 1. doi: 10.1002/cncr.26013.
    PubMed     Text format     Related articles    Abstract available



    February 2011
  79. CHAVEZ-MACGREGOR M , Zhao H, Fang S, Srokowski TP, et al
    Complications associated with erythropoietin-stimulating agents in patients with metastatic breast cancer: A Surveillance, Epidemiology, and End Results-Medicare Study.
    Cancer. 2011 Feb 24. doi: 10.1002/cncr.25972.
    PubMed     Text format     Related articles    Abstract available



  80. PRINTZ C
    Experts weigh in on BRCA1/2 mutations and prophylactic surgeries.
    Cancer. 2011;117:659.
    PubMed     Text format     Related articles   



  81. PRINTZ C
    New data on BRCA mutations and prophylactic surgeries.
    Cancer. 2011;117:657.
    PubMed     Text format     Related articles   



  82. GONG Y , Han EY, Guo M, Pusztai L, et al
    Stability of estrogen receptor status in breast carcinoma: a comparison between primary and metastatic tumors with regard to disease course and intervening systemic therapy.
    Cancer. 2011;117:705-13.
    PubMed     Text format     Related articles    Abstract available



  83. HELLQUIST BN , Duffy SW, Abdsaleh S, Bjorneld L, et al
    Effectiveness of population-based service screening with mammography for women ages 40 to 49 years: evaluation of the Swedish Mammography Screening in Young Women (SCRY) cohort.
    Cancer. 2011;117:714-22.
    PubMed     Text format     Related articles    Abstract available



  84. NAGELKERKE A , Mujcic H, Bussink J, Wouters BG, et al
    Hypoxic regulation and prognostic value of LAMP3 expression in breast cancer.
    Cancer. 2011 Feb 11. doi: 10.1002/cncr.25938.
    PubMed     Text format     Related articles    Abstract available



  85. SARKISSYAN M , Wu Y, Vadgama JV
    Obesity is associated with breast cancer in African-American women but not hispanic women in South Los Angeles.
    Cancer. 2011 Feb 8. doi: 10.1002/cncr.25956.
    PubMed     Text format     Related articles    Abstract available



  86. NAOI Y , Kishi K, Tanei T, Tsunashima R, et al
    High genomic grade index associated with poor prognosis for lymph node-negative and estrogen receptor-positive breast cancers and with good response to chemotherapy.
    Cancer. 2011;117:472-9.
    PubMed     Text format     Related articles    Abstract available



  87. HUANG SC , Lee JK, Smith EJ, Doctolero RT, et al
    Evidence for an hMSH3 defect in familial hamartomatous polyps.
    Cancer. 2011;117:492-500.
    PubMed     Text format     Related articles    Abstract available



    January 2011
  88. MEIER A , Satzger I, Volker B, Kapp A, et al
    Reply to Assessment of capsular melanoma cell deposits in sentinel lymph nodes.
    Cancer. 2011 Jan 24. doi: 10.1002/cncr.25789.
    PubMed     Text format     Related articles   



  89. BERTSCH HP , Kretschmer L
    Assessment of capsular melanoma cell deposits in sentinel lymph nodes.
    Cancer. 2011 Jan 24. doi: 10.1002/cncr.25785.
    PubMed     Text format     Related articles   



  90. BOUCHARDY C , Benhamou S, Schaffar R, Verkooijen HM, et al
    Lung cancer mortality risk among breast cancer patients treated with anti-estrogens.
    Cancer. 2011 Jan 24. doi: 10.1002/cncr.25638.
    PubMed     Text format     Related articles    Abstract available



  91. MIRANDA PY , Wilkinson AV, Etzel CJ, Zhou R, et al
    Policy implications of early onset breast cancer among Mexican-origin women.
    Cancer. 2011;117:390-7.
    PubMed     Text format     Related articles    Abstract available



  92. COLEMAN R , Cook R, Hirsh V, Major P, et al
    Zoledronic acid use in cancer patients: more than just supportive care?
    Cancer. 2011;117:11-23.
    PubMed     Text format     Related articles    Abstract available



  93. REDIG AJ , Brannigan R, Stryker SJ, Woodruff TK, et al
    Incorporating fertility preservation into the care of young oncology patients.
    Cancer. 2011;117:4-10.
    PubMed     Text format     Related articles    Abstract available



  94. VRANIC S , Teruya B, Repertinger S, Ulmer P, et al
    Assessment of HER2 gene status in breast carcinomas with polysomy of chromosome 17.
    Cancer. 2011;117:48-53.
    PubMed     Text format     Related articles    Abstract available



  95. WAI ES , Lesperance ML, Alexander CS, Truong PT, et al
    Effect of radiotherapy boost and hypofractionation on outcomes in ductal carcinoma in situ.
    Cancer. 2011;117:54-62.
    PubMed     Text format     Related articles    Abstract available



  96. KUERER HM , Buzdar AU, Mittendorf EA, Esteva FJ, et al
    Biologic and immunologic effects of preoperative trastuzumab for ductal carcinoma in situ of the breast.
    Cancer. 2011;117:39-47.
    PubMed     Text format     Related articles    Abstract available



    December 2010
  97. MAUBEC E , Chaudru V, Mohamdi H, Grange F, et al
    Characteristics of the coexistence of melanoma and renal cell carcinoma.
    Cancer. 2010;116:5716-24.
    PubMed     Text format     Related articles    Abstract available



  98. PRINTZ C
    Arsenic nanoparticle holds promise in blocking aggressive breast cancer.
    Cancer. 2010;116:5567.
    PubMed     Text format     Related articles   



  99. MCCARTHY CM , Klassen AF, Cano SJ, Scott A, et al
    Patient satisfaction with postmastectomy breast reconstruction: a comparison of saline and silicone implants.
    Cancer. 2010;116:5584-91.
    PubMed     Text format     Related articles    Abstract available



  100. LOBB R , Ayanian JZ, Allen JD, Emmons KM, et al
    Stage of breast cancer at diagnosis among low-income women with access to mammography.
    Cancer. 2010;116:5487-96.
    PubMed     Text format     Related articles    Abstract available



  101. JUSTENHOVEN C , Winter S, Hamann U, Haas S, et al
    The frameshift polymorphism CYP3A43_74_delA is associated with poor differentiation of breast tumors.
    Cancer. 2010;116:5358-64.
    PubMed     Text format     Related articles    Abstract available



    November 2010
  102. KELLY CM , Krishnamurthy S, Bianchini G, Litton JK, et al
    Utility of oncotype DX risk estimates in clinically intermediate risk hormone receptor-positive, HER2-normal, grade II, lymph node-negative breast cancers.
    Cancer. 2010;116:5161-7.
    PubMed     Text format     Related articles    Abstract available



    October 2010
  103. FREEDMAN RA , Virgo KS, He Y, Pavluck AL, et al
    The association of race/ethnicity, insurance status, and socioeconomic factors with breast cancer care.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



    September 2010
  104. ALDERMAN AK , Bynum J, Sutherland J, Birkmeyer N, et al
    Surgical treatment of breast cancer among the elderly in the United States.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



  105. NAKAYA N , Saito-Nakaya K, Bidstrup PE, Dalton SO, et al
    Increased risk of severe depression in male partners of women with breast cancer.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



  106. HOLMES JP , Clifton GT, Patil R, Benavides LC, et al
    Use of booster inoculations to sustain the clinical effect of an adjuvant breast cancer vaccine: from US Military Cancer Institute Clinical Trials Group Study I-01 and I-02.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



  107. YEN TW , Czypinski LK, Sparapani RA, Guo C, et al
    Socioeconomic factors associated with adjuvant hormone therapy use in older breast cancer survivors.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



  108. LIU LC , Lang JE, Lu Y, Roe D, et al
    Intraoperative frozen section analysis of sentinel lymph nodes in breast cancer patients: a meta-analysis and single-institution experience.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



    August 2010
  109. MELL LK , Jeong JH, Nichols MA, Polite BN, et al
    Predictors of competing mortality in early breast cancer.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



  110. ANDRYKOWSKI MA , Donovan KA, Laronga C, Jacobsen PB, et al
    Prevalence, predictors, and characteristics of off-treatment fatigue in breast cancer survivors.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



  111. DANESE MD , Lalla D, Brammer M, Doan Q, et al
    Estimating recurrences prevented from using trastuzumab in HER-2/neu-positive adjuvant breast cancer in the United States.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



  112. TAN YO , Han S, Lu YS, Yip CH, et al
    The prevalence and assessment of ErbB2-positive breast cancer in Asia: a literature survey.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



    July 2010
  113. CORMIER JN , Askew RL, Mungovan KS, Xing Y, et al
    Lymphedema beyond breast cancer: a systematic review and meta-analysis of cancer-related secondary lymphedema.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



  114. LIPTON A , Kostler WJ, Leitzel K, Ali SM, et al
    Quantitative HER2 protein levels predict outcome in fluorescence in situ hybridization-positive patients with metastatic breast cancer treated with trastuzumab.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available



Thank you for your interest in scientific medicine.


Amedeo is a Flying Publisher website.

   Design: